CEBP  Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diorio, C.
Right arrow Articles by Brisson, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diorio, C.
Right arrow Articles by Brisson, J.
Cancer Epidemiology Biomarkers & Prevention Vol. 14, 1065-1073, May 2005
© 2005 American Association for Cancer Research

Insulin-Like Growth Factor-I, IGF-Binding Protein-3, and Mammographic Breast Density

Caroline Diorio1,3, Michael Pollak6, Celia Byrne7, Benoît Mâsse8, Nicole Hébert-Croteau9, Martin Yaffe10, Gary Coté2,5, Sylvie Bérubé1,2, Carol Morin2,4 and Jacques Brisson1,2,3

1 Unité de recherche en santé des populations and 2 Centre des maladies du sein Deschênes-Fabia, Centre hospitalier affilié universitaire de Québec; 3 Department of Social and Preventive Medicine and 4 Laboratoire d'anatomo-pathologie, département de biologie médicale, Laval University; and 5 Clinique Radiologique Audet, Quebec, Quebec, Canada; 6 Departments of Medicine and Oncology, Cancer Prevention Research Unit, Lady Davis Institute of the Jewish General Hospital and McGill University, Montreal, Quebec, Canada; 7 Lombardi Cancer Center, Georgetown University, Washington, District of Columbia; 8 Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; 9 Institut national de santé publique du Québec et Centre de recherche, Hôpital Charles LeMoyne, Greenfield, Quebec, Canada; and 10 Sunnybrook & Women's College Health Sciences Centre, University of Toronto, Toronto, Canada

Requests for reprints: Jacques Brisson, Unité de recherche en santé des populations, Centre hospitalier affilié universitaire de Québec, Hôpital Saint-Sacrement, 1050 Chemin Sainte-Foy, Quebec, Quebec, Canada G1S 4L8. Phone: 418-682-7392; Fax: 418-682-7949. E-mail: jacques.brisson{at}uresp.ulaval.ca

Some studies have suggested that insulin-like growth factor (IGF) pathway is related to premenopausal breast density, one of the strongest known breast cancer risk factors. This study was designed specifically to test the hypothesis that higher levels of IGF-I and lower levels of IGF-binding protein (IGFBP)-3 are associated with high mammographic breast density among premenopausal but not among postmenopausal women. A total of 783 premenopausal and 791 postmenopausal healthy women were recruited during screening mammography examinations. Blood samples were collected at the time of mammography, and plasma IGF-I and IGFBP-3 levels were measured by ELISA. Mammographic breast density was estimated using a computer-assisted method. Spearman's partial correlation coefficients (rs) were used to evaluate the associations. Adjusted mean breast density was assessed by joint levels of IGF-I and IGFBP-3 using generalized linear models. Among premenopausal women, high levels of IGF-I and low levels of IGFBP-3 were independently correlated with high breast density (rs = 0.083; P = 0.021 and rs = –0.124; P = 0.0005, respectively). Correlation of IGF-I with breast density was stronger among women in the lowest tertile of IGFBP-3 than among those in the highest tertile of IGFBP-3 (rs = 0.138; P = 0.027 and rs = –0.039; P = 0.530, respectively). In contrast, the correlation of IGFBP-3 with breast density was stronger among women in the highest tertile of IGF-I than among those in the lowest tertile of IGF-I (rs = –0.150; P = 0.016 and rs = –0.008; P = 0.904, respectively). Women in the combined top tertile of IGF-I and bottom tertile of IGFBP-3 had higher mean breast density than those in the combined bottom tertile of IGF-I and top tertile of IGFBP-3 (53.8% versus 40.9%; P = 0.014). No significant association was observed among postmenopausal women. Our findings confirm that IGF-I and IGFBP-3 are associated with breast density among premenopausal women. They provide additional support for the idea that, among premenopausal women, these growth factors may affect breast cancer risk, at least in part, through their influence on breast tissue morphology as reflected on mammogram.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Diorio, J. Brisson, S. Berube, and M. Pollak
Genetic Polymorphisms Involved in Insulin-like Growth Factor (IGF) Pathway in Relation to Mammographic Breast Density and IGF Levels
Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 880 - 888.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. N Pollak
Insulin, insulin-like growth factors, insulin resistance, and neoplasia
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 820S - 821S.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
T. Sellers, C. Vachon, V. Pankratz, C. Janney, Z Fredericksen, K. Brandt, Y Huang, F. Couch, L. Kushi, and J. Cerhan
Association of Childhood and Adolescent Anthropometric Factors, Physical Activity, and Diet with Adult Mammographic Breast Density
Am. J. Epidemiol., August 15, 2007; 166(4): 456 - 464.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. Brisson, S. Berube, C. Diorio, M. Sinotte, M. Pollak, and B. Masse
Synchronized Seasonal Variations of Mammographic Breast Density and Plasma 25-Hydroxyvitamin D
Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 929 - 933.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Verheus, P. H.M. Peeters, R. Kaaks, P. A.H. van Noord, D. E. Grobbee, and C. H. van Gils
Premenopausal Insulin-Like Growth Factor-I Serum Levels and Changes in Breast Density over Menopause
Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 451 - 457.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Vachon, K. R. Brandt, K. Ghosh, C. G. Scott, S. D. Maloney, M. J. Carston, V. S. Pankratz, and T. A. Sellers
Mammographic Breast Density as a General Marker of Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 43 - 49.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. Bremnes, G. Ursin, N. Bjurstam, S. Rinaldi, R. Kaaks, and I. T. Gram
Insulin-like Growth Factor and Mammographic Density in Postmenopausal Norwegian Women
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 57 - 62.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. D. Tran, C. Diorio, S. Berube, M. Pollak, and J. Brisson
Relation of insulin-like growth factor (IGF) I and IGF-binding protein 3 concentrations with intakes of fruit, vegetables, and antioxidants
Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1518 - 1526.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. F. Boyd, L. J. Martin, L. Sun, H. Guo, A. Chiarelli, G. Hislop, M. Yaffe, and S. Minkin
Body Size, Mammographic Density, and Breast Cancer Risk.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2086 - 2092.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. J. Fabian and B. F. Kimler
Mammographic Density: Use in Risk Assessment and as a Biomarker in Prevention Trials
J. Nutr., October 1, 2006; 136(10): 2705S - 2708S.
[Full Text] [PDF]


Home page
Cancer Res.Home page
C. M. Blakely, A. J. Stoddard, G. K. Belka, K. D. Dugan, K. L. Notarfrancesco, S. E. Moody, C. M. D'Cruz, and L. A. Chodosh
Hormone-Induced Protection against Mammary Tumorigenesis Is Conserved in Multiple Rat Strains and Identifies a Core Gene Expression Signature Induced by Pregnancy.
Cancer Res., June 15, 2006; 66(12): 6421 - 6431.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
I. dos Santos Silva, N. Johnson, B. De Stavola, G. Torres-Mejia, O. Fletcher, D. S. Allen, N. E. Allen, T. J. Key, I. S. Fentiman, J. M.P. Holly, et al.
The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women.
Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 449 - 455.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Diorio, S. Berube, C. Byrne, B. Masse, N. Hebert-Croteau, M. Yaffe, G. Cote, M. Pollak, and J. Brisson
Influence of Insulin-like Growth Factors on the Strength of the Relation of Vitamin D and Calcium Intakes to Mammographic Breast Density
Cancer Res., January 1, 2006; 66(1): 588 - 597.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. Kaaks, C. Diorio, and J. Brisson
Insulin-Like Growth Factor-I and Mammographic Breast Density
Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 3019 - 3019.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Diorio, M. Pollak, C. Byrne, B. Masse, N. Hebert-Croteau, M. Yaffe, G. Cote, S. Berube, and J. Brisson
Levels of C-Peptide and Mammographic Breast Density
Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2661 - 2664.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.